Kleanthis G Xanthopoulos - Net Worth and Insider Trading
Kleanthis G Xanthopoulos Net Worth
The estimated net worth of Kleanthis G Xanthopoulos is at least $1,552 dollars as of 2024-04-25. Kleanthis G Xanthopoulos is the President and CEO of Regulus Therapeutics Inc and owns about 699 shares of Regulus Therapeutics Inc (RGLS) stock worth over $1,552. Kleanthis G Xanthopoulos is also the Director of Zosano Pharma Corp and owns about 31 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Kleanthis G Xanthopoulos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kleanthis G Xanthopoulos has not made any transactions after 2016-08-19 and currently still holds the listed stock(s).
Transaction Summary of Kleanthis G Xanthopoulos
Kleanthis G Xanthopoulos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kleanthis G Xanthopoulos owns 4 companies in total, including Zosano Pharma Corp () , Seelos Therapeutics Inc () , and Regulus Therapeutics Inc () among others .
Click here to see the complete history of Kleanthis G Xanthopoulos’s form 4 insider trades.
Insider Ownership Summary of Kleanthis G Xanthopoulos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Zosano Pharma Corp | 2020-06-25 | director | |
| Seelos Therapeutics Inc | 2014-01-02 | director | |
| Regulus Therapeutics Inc | 2015-04-21 | director & President & CEO | |
| Ionis Pharmaceuticals Inc | 2007-12-03 | President of Regulus |
Kleanthis G Xanthopoulos Latest Holdings Summary
Kleanthis G Xanthopoulos currently owns a total of 2 stocks. Among these stocks, Kleanthis G Xanthopoulos owns 699 shares of Regulus Therapeutics Inc (RGLS) as of April 21, 2015, with a value of $1,552 and a weighting of 100%. Kleanthis G Xanthopoulos also owns 31 shares of Zosano Pharma Corp (ZSANQ) as of August 19, 2016, with a value of $0 and a weighting of 0%.
Latest Holdings of Kleanthis G Xanthopoulos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2015-04-21 | 699 | 2.22 | 1,552 |
| ZSANQ | Zosano Pharma Corp | 2016-08-19 | 31 | 0.00 | 0 |
Holding Weightings of Kleanthis G Xanthopoulos
Kleanthis G Xanthopoulos Form 4 Trading Tracker
According to the SEC Form 4 filings, Kleanthis G Xanthopoulos has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the sale of 1,667 shares on April 21, 2015, which brought Kleanthis G Xanthopoulos around $3 Million.
According to the SEC Form 4 filings, Kleanthis G Xanthopoulos has made a total of 0 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years. The most-recent trade in Zosano Pharma Corp is the acquisition of 23 shares on August 19, 2016, which cost Kleanthis G Xanthopoulos around $21,014.
Insider Trading History of Kleanthis G Xanthopoulos
- 1
Kleanthis G Xanthopoulos Trading Performance
GuruFocus tracks the stock performance after each of Kleanthis G Xanthopoulos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kleanthis G Xanthopoulos is -52.77%. GuruFocus also compares Kleanthis G Xanthopoulos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kleanthis G Xanthopoulos within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kleanthis G Xanthopoulos's insider trading performs compared to the benchmark.
Performance of Kleanthis G Xanthopoulos
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -40 | -52.77 | 149.6 | -34.52 | -60.5 | -52.03 |
| Relative Return to S&P 500(%) | -37.95 | -52.68 | 141.94 | -45.59 | -74.78 | -62.24 |
Kleanthis G Xanthopoulos Ownership Network
Ownership Network List of Kleanthis G Xanthopoulos
Ownership Network Relation of Kleanthis G Xanthopoulos
Kleanthis G Xanthopoulos Owned Company Details
What does Zosano Pharma Corp do?
Who are the key executives at Zosano Pharma Corp?
Kleanthis G Xanthopoulos is the director of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .
Zosano Pharma Corp () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zosano Pharma Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Zosano Pharma Corp Insider Transactions
Kleanthis G Xanthopoulos Mailing Address
Above is the net worth, insider trading, and ownership report for Kleanthis G Xanthopoulos. You might contact Kleanthis G Xanthopoulos via mailing address: 9050 Camino Santa Fe, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
